Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …

Children were relatively spared during COVID-19 pandemic. However, the recently reported
hyperinflammatory syndrome with overlapping features of Kawasaki disease and toxic shock …

Background Many patients with COVID-19 have been treated with plasma containing anti-
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …

Background Casirivimab and imdevimab are non-competing monoclonal antibodies that
bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike …

Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

Objective Juvenile dermatomyositis (DM) is a rare and severe autoimmune condition
characterized by rash and proximal muscle weakness. While some patients respond to …

Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening disease
occurring several weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Objective To evaluate the impact of anti-Tumour Necrosis Factor-α (anti-TNF) treatment on
the occurrence of vasculitic ischaemic events in patients with deficiency of adenosine …

Background During the COVID-19 outbreak, reports have surfaced of children who present
with features of a multisystem inflammatory syndrome with overlapping features of Kawasaki …

Systemic lupus erythematosus (SLE) is a systemic autoimmune/inflammatory disease.
Patients diagnosed with juvenile-onset SLE (jSLE), when compared to individuals with adult …